Connecta Therapeutics
PrivateLast Round
Grant
Sep 9, 2025
Total Funding Raised
$8.56M
Momentum Score
50 /100
Company Overview
Connecta Therapeutics is a biotechnology company developing new treatments for central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Connecta Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Connecta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 9, 2025 | ||||
| Grant | Feb 12, 2024 | ||||
| Debt | Jun 6, 2023 | ||||
| Grant | Feb 3, 2022 | ||||
| Seed | Sep 28, 2020 |
Key People
Founding team and executive leadership
Connecta Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
Secured $2.73M from the European Innovation Council.
- Jul 1, 2025
Monthly visitors grew 236% MoM, reaching 1K.
Connecta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Connecta Therapeutics's valuation, stock price, and market status.